These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33445991)

  • 21. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with peritoneal metastasis.
    Lin EK; Hsieh MC; Chen CH; Lu YJ; Wu SY
    Medicine (Baltimore); 2016 Dec; 95(52):e5522. PubMed ID: 28033247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of lung ultrasound for extravascular lung water volume estimation during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Mittal AK; Jaipuria J; Patel A; Bhatnagar V; Chawla R; Singh S
    Indian J Anaesth; 2021 Jun; 65(6):458-464. PubMed ID: 34248189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of cardiac output monitoring to guide the administration of intravenous fluid during hyperthermic intraperitoneal chemotherapy.
    Thanigaimani K; Mohamed F; Cecil T; Moran BJ; Bell J
    Colorectal Dis; 2013 Dec; 15(12):1537-42. PubMed ID: 24119169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.
    Narasimhan V; Britto M; Pham T; Warrier S; Naik A; Lynch AC; Michael M; Tie J; Ramsay R; Heriot A
    Dis Colon Rectum; 2019 Oct; 62(10):1195-1203. PubMed ID: 31490828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rare case of recurrent epidermoid anal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy-case report.
    Pravong V; Brind'Amour A; Sidéris L; Dubé P; Tremblay JF
    World J Surg Oncol; 2020 Jul; 18(1):152. PubMed ID: 32622361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prehabilitation of patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancy.
    Cortés-Guiral D; Mohamed F; Glehen O; Passot G
    Eur J Surg Oncol; 2021 Jan; 47(1):60-64. PubMed ID: 32063398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in hemostasis during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis.
    Falcón Araña L; Fuentes-García D; Roca Calvo MJ; Hernández-Palazón J; Gil Martínez J; Cascales Campos PA; Acosta Villegas FJ; Parrilla Paricio P
    Cir Esp; 2015 Oct; 93(8):496-501. PubMed ID: 25882334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for children, adolescents, and young adults: the first 50 cases.
    Hayes-Jordan A; Green H; Lin H; Owusu-Agyemang P; Mejia R; Okhuysen-Cawley R; Cortes J; Fitzgerald NE; McAleer MF; Herzog C; Huh WW; Anderson P
    Ann Surg Oncol; 2015 May; 22(5):1726-32. PubMed ID: 25564159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer.
    Lei Z; Wang Y; Wang J; Wang K; Tian J; Zhao Y; Chen L; Wang J; Luo J; Jia M; Tang H; He Q; Liao Q; Yang X; Guan T; Wang L; Cui S;
    JAMA Netw Open; 2020 Aug; 3(8):e2013940. PubMed ID: 32840622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features of pulmonary emboli in patients following cytoreductive surgery (peritonectomy) and hyperthermic intraperitoneal chemotherapy (hipec), a single centre experience.
    Vukadinovic V; Chiou JD; Morris DL
    Eur J Surg Oncol; 2015 May; 41(5):702-6. PubMed ID: 25680953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study.
    van der Kaaij RT; Braam HJ; Boot H; Los M; Cats A; Grootscholten C; Schellens JH; Aalbers AG; Huitema AD; Knibbe CA; Boerma D; Wiezer MJ; van Ramshorst B; van Sandick JW
    JMIR Res Protoc; 2017 Jul; 6(7):e136. PubMed ID: 28705789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-related quality of life after interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with stage III ovarian cancer.
    Koole SN; Kieffer JM; K Sikorska ; Schagen van Leeuwen JH; Schreuder HWR; Hermans RH; de Hingh IH; van der Velden J; Arts HJ; van Ham MAPC; Aalbers AG; Verwaal VJ; Van de Vijver KK; Sonke GS; van Driel WJ; Aaronson NK
    Eur J Surg Oncol; 2021 Jan; 47(1):101-107. PubMed ID: 31128948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy, Part II: Implementation.
    Dunn D; Ciccarelli E; Moltzen N
    AORN J; 2019 Dec; 110(6):606-625. PubMed ID: 31774172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of CytoReductive surgery plus hyperthermic IntraPEritoneal chemotherapy (HIPEC) versus CytoReductive surgery for ovarian cancer patients: A systematic review and meta-analysis.
    Wang Y; Ren F; Chen P; Liu S; Song Z; Ma X
    Eur J Surg Oncol; 2019 Mar; 45(3):301-309. PubMed ID: 30786961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anesthetic management in patients undergoing hyperthermic chemotherapy.
    Raspe C; Piso P; Wiesenack C; Bucher M
    Curr Opin Anaesthesiol; 2012 Jun; 25(3):348-55. PubMed ID: 22517311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer.
    Polom K; Roviello G; Generali D; Marano L; Petrioli R; Marsili S; Caputo E; Marrelli D; Roviello F
    Int J Hyperthermia; 2016 May; 32(3):298-310. PubMed ID: 26984715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study.
    Di Leo A; Corvasce A; Weindelmayer J; Mason EJ; Casella F; de Manzoni G
    Updates Surg; 2020 Dec; 72(4):1207-1212. PubMed ID: 32410159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does early post-operative intraperitoneal chemotherapy (EPIC) for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) make a difference?
    Tan GH; Ong WS; Chia CS; Tham CK; Soo KC; Teo MC
    Int J Hyperthermia; 2016 May; 32(3):281-8. PubMed ID: 26862667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study.
    Petrillo M; Zucchetti M; Cianci S; Morosi L; Ronsini C; Colombo A; D'Incalci M; Scambia G; Fagotti A
    J Gynecol Oncol; 2019 Jul; 30(4):e59. PubMed ID: 31074245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.